Delivery Order SPE2DB22D2206-SPE2DB24FHY22

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,718.59 firm-fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has a period of performance through November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $8,620.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $2,635.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for the supply of a wide range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,756.28 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,170.47 firm fixed-price delivery order is for the pharmaceutical product ORILISSA 150 MG TABLET 7S, with a completion date of June 13, 2025. The contract is not set aside for any small business designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,863.66 and is a delivery order for ORILISSA 150 MG TABLET 7S. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $2,251.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $4,594.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150MG TAB 28S, a prescription medication, to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB3K4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,755.90, is a Firm Fixed Price Delivery Order for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,235.33 firm fixed-price contract is for the delivery of the drug ORILISSA 150 MG TABLET 7S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHY22
    Delivery Order

This federal contract award, valued at $19,840.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract is for the provision of ORILISSA 150 MG TABLET 7S, a specialty medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contract portfolio, including a separate IDC with the Department of Justice Federal Bureau of Investigation, demonstrates its critical role in supplying a wide range of essential pharmaceutical and medical commodities to various government agencies and healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 5/17/25, 10:06 AM